Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide

ROSWELL, Ga. - April 16, 2014 - PRLog -- Cervical cancer is one of the deadliest cancers among woman all over the world. However in the past few decades, mortality from cervical cancer has significantly decreased in developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other popular tests used across world. VIA test is most adoptable test in developing countries as it is cheaper in comparison to Pap smear test and HPV DNA test.

Cervical cancer test market is dominated by United States in 2013. Germany and United Kingdom are other top two leaders in this market place. In Asian region, China and India are top two countries having largest cervical cancer test population. Few countries have also shown a decline in cervical cancer test market. However VIA test market accounts for largest share in cervical cancer test market in the case of developing countries like India and China.

A high prevalence of HPV-infected patients across the globe, rising incidences of teenage sexual cases, a rising number of organized cervical cancer programs initiated by governments and NGOs and introduction of low cost VIA test are some of the major growth drivers for the cervical cancer test market. However, lack of insufficient healthcare infrastructure and lack of cervical cancer screening awareness are the major hinder for cervical testing market.

Renub Research report titled "Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide” provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 232 page report with 240 Figures and 14 Table provides a complete analysis of top 20 Countries Cervical Cancer Test Market & Population. All the 20 countries in the report have been studied from 3 viewpoints.

1. Cervical cancer Test Population (2007-2020)

    •  Pap smear test population (2007-2020)
    •  HPV DNA test population (2007-2020)
    •  VIA test Population (2007-2020)

2. Cervical Cancer Mortality Population (2001-2011)

3. Cervical Cancer Test Market (2007-2020)

   •  Pap smear test market (2007-2020)
   •  HPV DNA test market (2007-2020)
   •  VIA test market (2007-2020)

All the 20 Countries studied in the report are as follows

1. United Kingdom
2. France
3. Germany
4. Italy
5. Spain
6. Sweden
7. Switzerland
8. Norway
9. Netherlands
10. United States
11. Canada
12. Japan
13. Korea
14. Singapore
15. Malaysia
16. Australia
17. India
18. China
19. Thailand
20. Indonesia

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Click here to view the report Details: http://renub.com/report/cervical-cancer-test-market-patie...

For more information visit: http://www.renub.com/


Contact Us

Ankit Mishra
Sr. Manager - Publisher Relation
Sales & Marketing Div.
Renub Research
Email: info@renub.com
Phone:  +1-678-302-0700 (USA) , +91-120-4219-822, +91-120-254-5750 (India)
Web: http://www.renub.com/